kevindalby

  Originally published on   iwdn.net Cancer research continues to evolve, generating new fascinating discoveries daily. Over the past few decades, our understanding of cancer has improved significantly. Here,  Austin, TX professor Kevin Dalby  reveals five interesting facts about cancer you may not have heard of before.   Fact #1. In 2019 the  five most common cancer types  that killed women were lung & bronchus, breast, colon & rectum, pancreas, and ovary. For men, the most common cancers are lung & bronchus, prostate, colon & rectum, pancreas, and liver & intrahepatic bile duct.   Fact #2. Even though 67% of Americans diagnosed with cancer survive five or more years, cancer is the  second leading cause of death  globally. It accounted for 1 in 6 deaths worldwide and was responsible for an estimated 9.6 million deaths in 2018.   Fact #3. The  Skin Cancer Foundation reports  that there are more than 419...

  Originally published on   agreensign.com Did you know: Viruses are the cause of a large number of cancerous tumors. This alarming fact is the reason for the urgency behind the research scientists are pursuing concerning treatments of such virus sparked cancers. Immunotherapy is one of the promising treatment choices used to treat a different variety of tumors. Kevin Dalby, Austin -based scientist, working on cancer drug discovery, is currently studying the mechanisms of cancer cell signaling to develop targeted therapeutics. Through his research, Dalby is familiar with the use of checkpoint inhibitors as immunotherapy agents for virus-related cancers. Dalby goes into some detail on how checkpoint inhibitors are used in combination with individualized precision medicine for the treatment of virus-related cancers. Comprehending Immunotherapy A type of cancer treatment that assists in enhancing the  body’s natural defense  to battle cancer is known as immunotherapy. T...

Originally published on  thriveglobal.com Life expectancy in the United States is about 78 years, though longevity is not without medical concerns. As many as one in three Americans will develop malignant cells in their lifetime. While the scientific community has significantly increased their understanding of cancer in recent years and applied that knowledge to treatment, prevention research remains a top priority; however, since cancer is a series of diseases, the exact cause is not always known. Genetics plays an important role, yet so does diet and lifestyle. Dr. Kevin Dalby, professor of chemical biology and medicinal chemistry, is studying the mechanisms of cancer cells and currently working on cancer drug discovery. His research primarily focuses on developing targeted therapeutics, but he does acknowledge that specific behavioral changes can help lower a person’s risk for cancer. The Harvard School of Public Health estimates that 75% of American cancer deaths c...